Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRA1 Inhibitors

PRA1 inhibitors constitute a sophisticated subclass of chemical entities that delve into the intricate realm of cellular processes. These inhibitors are meticulously fashioned to interact with the PRA1 protein, a linchpin in the intricate machinery of intracellular membrane trafficking and vesicle biogenesis. The acronym PRA1, denoting Prenylated Rab Acceptor 1, encapsulates its role as a pivotal orchestrator of molecular shuttling within cells. Embedded within diverse cellular compartments, PRA1 intricately regulates the trafficking of molecules and organelles, ensuring their precise delivery to designated cellular locales. PRA1 inhibitors, through their tailored molecular configuration, engage with precision at the active site of the protein, disrupting its functional landscape. This disruption cascades through the labyrinthine network of intracellular membrane dynamics, triggering a ripple effect across vesicle transport mechanisms and cellular compartmentalization.

The artistry behind the design of PRA1 inhibitors lies in the meticulous scrutiny of the protein's structural topography. By capitalizing on key molecular interactions, these inhibitors achieve a finely tuned binding affinity for PRA1. The inhibitors' interaction with the protein introduces a novel layer of modulation, which potentially recalibrates the cellular orchestra, influencing the flow of molecular traffic within the cell. As the exploration of PRA1 inhibitors advances, researchers unveil an evolving comprehension of the exquisite interplay between these compounds and cellular processes. This nuanced understanding extends beyond the confines of static cellular pathways, encompassing the dynamic choreography of molecular movement. The ongoing investigation into PRA1 inhibitors thus promises to reveal deeper insights into the fundamental principles governing cellular trafficking and opens avenues for the exploration of novel facets of cell biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SGC707

1687736-54-4sc-507461
1 mg
$48.00
(0)

Developed by the Structural Genomics Consortium (SGC), explored for cancer therapy.

AMI-1, sodium salt

20324-87-2sc-205928
sc-205928A
5 mg
25 mg
$114.00
$398.00
2
(1)

Competitive PRMT1 inhibitor, used in laboratory research.

TC-E 5003

17328-16-4sc-397056
50 mg
$151.00
3
(0)

Selective PRMT1 inhibitor, studied for anti-inflammatory effects.

MS023

1831110-54-3sc-507463
5 mg
$165.00
(0)

Merck's PRMT1 inhibitor, explored for various diseases.

eIF4E/eIF4G Interaction Inhibitor, 4EGI-1

315706-13-9sc-202597
10 mg
$265.00
14
(1)

Indirect PRMT1 inhibitor, impacts cellular processes involving PRMT1.